GSK and J&J lead in vaccines research – but pricing still an issue


Andrew McConaghie writes about the Access to Vaccines Index for PharmaPhorum. He leads with the finding that GSK and Johnson & Johnson are leading R&D investment in vaccines, and the field is producing the first ever vaccines for conditions such as Ebola and a range of deadly bacterial infections.

Follow us and engage with us on LinkedIn and Twitter.